Europe Diabetes Devices Market Size, Share & Trends Report

Europe Diabetes Devices Market Size, Share & Trends Analysis Report By Device Type (Self-monitoring & Diagnostic (Digital & Analog Blood Glucose Monitors)), Delivery Type (Pumps, Pen, Syringes, Injectors) And Segment Forecast, 2019 - 2026

  • Report ID: GVR-3-68038-967-8
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2015 - 2017
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Research Methodology
                   1.2 Information Procurement
                       1.2.1 Purchased Database
                       1.2.2 Gvr’s Internal Database
                       1.2.3 Secondary Sources
                       1.2.4 Primary Research
                       1.2.5 Details of Primary Research
                           1.2.5.1 Data for Primary Interviews in Europe
                   1.3 Information or Data Analysis
                       1.3.1 DATA ANALYSIS MODELS
                   1.4 Market Formulation & Validation
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
                   3.1 Market lineage outlook
                       3.1.1 Parent Market Outlook
                       3.1.2 Related/Ancillary Market Outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 User Perspective Analysis by Stage
                       3.3.1 Consumer Behavior Analysis
                       3.3.2 Market Influencer Analysis
                   3.4 List of Key End Users, by region, by product, by country
                   3.5 Regulatory Framework
                       3.5.1 Reimbursement Framework
                       3.5.2 Standards & Compliances 
                   3.6 Market Dynamics
                       3.6.1 Market Driver Analysis
                           3.6.1.1 Growing prevalence of obesity
                           3.6.1.2 Increasing number of diabetes patient
                           3.6.1.3 Technological innovation and product advancements
                           3.6.1.4 Untapped opportunities in the developing economies
                   3.7 Market Restraint Analysis
                       3.7.1 Stringent government rules and regulation
                       3.7.2 Industry Challenges
                   3.8 Europe Diabetes Devices: Market Analysis Tools
                       3.8.1. Industry Analysis - Porter’s
                           3.8.1.1 Supplier Power
                           3.8.1.2 Buyer Power
                           3.8.1.3 Substitution Threat
                           3.8.1.4 Threat from new entrant (low)
                           3.8.1.5 Competitive rivalry
                       3.8.2 PESTEL Analysis
                           3.8.2.1 Political Landscape
                           3.8.2.2 Environmental Landscape
                           3.8.2.3 Social Landscape
                           3.8.2.4 Technology Landscape
                           3.8.2.5 Legal Landscape
                   3.9 Major Deals & Strategic Alliances Analysis
                       3.9.1 Joint Ventures
                       3.9.2 Mergers & Acquisitions
                       3.9.3 Licensing & Partnership
                       3.9.4 Technology Collaborations
                       3.9.5 Strategic Divestments
                   3.10 Market Entry Strategies
Chapter 4 Europe Diabetes Devices Market: Product Estimates & Trend Analysis
                   4.1 Diabetes Devices: Product Analysis
                   4.2 Monitoring and Diagnostic Devices
                       4.2.1 Monitoring and diagnostic devices market, by type, 2015 - 2026 (USD Million)
                       4.2.2 Digital glucose monitor
                           4.2.2.1 Digital glucose monitor Market, 2015 - 2026 (USD Million)
                       4.2.3 Analog Glucose Monitor
                           4.2.3.1 Analog glucose monitor market, 2015 - 2026 (USD Million)
                       4.2.4 Continuous glucose monitor
                           4.2.4.1 Continuous glucose monitor Market, 2015 - 2026 (USD Million)
                   4.3 Insulin Delivery Devices
                       4.3.1 Insulin delivery devices market, by type, 2015 - 2026 (USD Million)
                       4.3.2 Pens
                           4.3.2.1 Pens market, 2015 - 2026 (USD Million)
                       4.3.3 Pumps
                           4.3.3.1 Pumps market, 2015 - 2026 (USD Million)
                       4.3.4 Syringes
                           4.3.4.1 Syringes market, 2015 - 2026 (USD Million)
                       4.3.5 Jet Injector
                           4.3.5.1 Jet Injector market, 2015 - 2026 (USD Million)
Chapter 5 Europe Diabetes Devices: Regional Estimates & Trend Analysis
                   5.1 Europe
                   5.2 Europe diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.1 U.K.
                           5.2.1.1 U.K. diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.2 Germany
                           5.2.2.1 Germany diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.3 France
                           5.2.3.1 France diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.4 Italy
                           5.2.4.1 Italy diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.5 Spain
                           5.2.5.1 Spain diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.6 Poland
                           5.2.6.1 Poland diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.7 Switzerland
                           5.2.7.1 Switzerland diabetes devices market, 2015 - 2026 (USD Million)
                       5.2.8 Austria
                           5.2.8.1 Austria diabetes devices market, 2015 - 2026 (USD Million)
Chapter 6 Company Profiles
                   6.1 Novo Nordisk A/S
                       6.1.1 Company overview
                       6.1.2 Financial performance
                       6.1.3 Product benchmarking
                       6.1.4 Strategic initiatives
                   6.2 Abbott Laboratories
                       6.2.1 Company overview
                       6.2.2 Financial performance
                       6.2.3 Product benchmarking
                       6.2.4 Strategic initiatives
                   6.3 Eli Lilly and Company
                       6.3.1 Company overview
                       6.3.2 Financial performance
                       6.3.3 Product benchmarking
                       6.3.4 Strategic initiatives
                   6.4 Medtronic, Inc.
                       6.4.1 Company overview
                       6.4.2 Financial performance
                       6.4.3 Product benchmarking
                       6.4.4 Strategic initiatives
                   6.5 Sanofi
                       6.5.1 Company overview
                       6.5.2 Financial performance
                       6.5.3 Product benchmarking
                       6.5.4 Strategic initiatives
                   6.6 Becton, Dickinson and Company
                       6.6.1 Company overview
                       6.6.2 Financial performance
                       6.6.3 Product benchmarking
                       6.6.4 Strategic initiatives
                   6.7 F Hoffmann-La Roche, Ltd.
                       6.7.1 Company overview
                       6.7.2 Financial performance
                       6.7.3 Product benchmarking
                       6.7.4 Strategic initiatives
                   6.8 B. Braun Melsungen AG
                       6.8.1 Company overview
                       6.8.2 Financial performance
                       6.8.3 Product benchmarking
                       6.8.4 Strategic initiatives
                   6.9 Ypsomed Holding AG
                       6.9.1 Company overview
                       6.9.2 Financial performance
                       6.9.3 Product benchmarking
                       6.9.4 Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 Europe diabetes devices market, by Region, 2015 - 2026 (USD Million)
Table 3 Europe diabetes devices market, by Product, 2015 - 2026 (USD Million)
Table 4 U.K. diabetes devices market Revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 5 U.K. diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 6 Germany diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 7 Germany. diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 8 France diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 9 France diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 10 Italy diabetes Devices Market Revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 11 Italy diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 12 Spain diabetes Devices Market Revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 13 Spain diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 14 Poland diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 15 Poland diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 16 Switzerland diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 17 Switzerland diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
Table 18 Austria diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million)
Table 19 Austria diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in Europe
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Europe diabetes devices market, 2018
Fig. 10 Europe diabetes devices segmentation
Fig. 11 Europe diabetes devices market trends
Fig. 12 Europe diabetes devices: market driver impact
Fig. 13 Europe diabetes devices: market restraint impact
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Europe diabetes devices market - pestle analysis
Fig. 16 Industry analysis - porter’s
Fig. 17 Europe diabetes devices competitive landscape: Market position analysis (Based on products, regional presence)
Fig. 18 Europe diabetes devices market: Product outlook key takeaways
Fig. 19 Europe diabetes devices: Product movement analysis
Fig. 20 Europe Diabetes Devices market: Material outlook key takeaways
Fig. 21 Others market, 2015 - 2026 (USD million)
Fig. 22 Regional marketplace, 2015 - 2026 (USD million)
Fig. 23 Europe diabetes devices market, 2015 - 2026 (USD million)
Fig. 24 U.K. diabetes devices market, 2015 - 2026 (USD million)
Fig. 25 Germany diabetes devices market, 2015 - 2026 (USD million)
Fig. 26 France diabetes devices market, 2015 - 2026 (USD million)
Fig. 27 Italy diabetes devices market, 2015 - 2026 (USD million)
Fig. 28 Spain diabetes devices market, 2015 - 2026 (USD million)
Fig. 29 Poland diabetes devices market, 2015 - 2026 (USD million)
Fig. 31 Switzerland diabetes devices market, 2015 - 2026 (USD million)
Fig. 32 Austria diabetes devices market, 2015 - 2026 (USD million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon